Section of Radiology & Molecular Imaging, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Department of Nuclear Medicine, University Hospital of Bordeaux, Bordeaux, France.
J Nucl Med. 2021 Jul;62(Suppl 2):26S-33S. doi: 10.2967/jnumed.120.246066.
Incidentalomas are reported in 3%-4% of patients who undergo abdominal anatomic imaging, making adrenal mass evaluation a common occurrence. An adrenal mass can be caused by a variety of pathologies, such as benign cortical and medullary tumors, malignant tumors (primary or secondary), cysts, hyperplasia, hemorrhage, or more rarely infection/inflammation processes. Functioning tumors usually have increased hormonal production but they are less common. Regardless of their functional status, some tumors have the potential to behave aggressively. Anatomic and functional imaging together with biologic evaluation play a vital role in adrenal pathology subtyping. Most patients are initially evaluated by CT or MRI, which allows for tumor characterization (to a certain extent) and can rule out malignant behavior based on the absence of tumor growth during longitudinal follow-up. In the remaining patients for whom CT or MRI fail to characterize the pathogenesis of adrenal tumors, the use of specialized molecular imaging techniques should be performed after hormonal screening. This review emphasizes well-established and emerging nuclear medicine imaging modalities and describes their use across various clinical scenarios.
偶发瘤在接受腹部解剖成像检查的患者中报告发生率为 3%-4%,这使得肾上腺肿块评估成为常见情况。肾上腺肿块可由多种病变引起,如良性皮质和髓质肿瘤、恶性肿瘤(原发性或继发性)、囊肿、增生、出血,或更罕见的感染/炎症过程。功能性肿瘤通常具有增加的激素产生,但它们较为少见。无论其功能状态如何,一些肿瘤都具有侵袭性生长的潜力。解剖和功能成像以及生物学评估在肾上腺病理学亚型分类中起着至关重要的作用。大多数患者最初通过 CT 或 MRI 进行评估,这允许对肿瘤进行特征描述(在一定程度上),并且可以根据纵向随访期间肿瘤无生长来排除恶性行为。对于 CT 或 MRI 未能对肾上腺肿瘤的发病机制进行特征描述的其余患者,应在激素筛查后使用专门的分子成像技术。这篇综述强调了成熟和新兴的核医学成像方式,并描述了它们在各种临床情况下的应用。